TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06032806

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: moderate intensity
Description: * Arm circles~* Leg swings~* Lunges

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity
Description: * Arm circles~* Leg swings~* Lunges~* Butt kicks
Study: NCT05383378

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: si-544
Description: Subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subcutaneous injection in the abdomen
Study: NCT06389617

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: supraclavicular block with 20mls of Ropivacaine 0.5% and Intravenous administered dexamethasone
Description: Comparing the onset of sensory, motor block, duration of motor block and analgesic duration

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: supraclavicular block with 20mls of Ropivacaine 0.5% and Intravenous administered dexamethasone
Description: Comparing the onset of sensory, motor block, duration of motor block and analgesic duration
Study: NCT05283434

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Arnica
Description: Patients will be assigned to the placebo (e.g., unmedicated sugar pill) or experimental group (e.g., Arnica 1M pellets) via a randomization chart from that only the research pharmacist will have access to. Subjects assigned to the experimental group will take the recommended doses of Arnica 1M coated sugar pellets (i.e., 2 pills to be taken every 4 waking hours over a 24 hours period), and will track their pain scores, swelling measurements, sleep rate, ibuprofen doses, adverse reactions, further ED visits, and the number of days/activities the patient has missed for 3 days following their enrollment in the study.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sugar pill placebo
Study: NCT03226795

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention:  Information-Motivation-Behavioral skills  intervention.
Description: * information -\> Reminders of medication: mobile application~* Motivation -\> Coaching by patients: intervention or coaching by an expert patient, animation of a social network of patients~* Behavioral skills -\> Accompaniment by professionals: therapeutic education, assessment of membership during medical visits, prioritization of treatments
Study: NCT05403645

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Movement With Mobilization
Description: with the help of Movement With Mobilization technique

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Exercise Therapy
Description: with the help of Exercise Therapy technique
Study: NCT06321523

Intervention type: DRUG
Intervention: Tafamidis 61 milligrams
Description: Tafamidis 61mg as provided in real-world practice
Study: NCT05126316

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lu AG09222
Description: Lu AG09222 will be administered per schedule specified in the arm description.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lu AG09222
Description: Lu AG09222 will be administered per schedule specified in the arm description.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo matching to Lu AG09222 will be administered per schedule specified in the arm description.
Study: NCT04609514

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Learn to Quit-HIV
Description: A smartphone app developed by the research team designed for people with HIV that provides Acceptance and Commitment Therapy skills to address smoking cessation.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: QuitGuide
Description: A smartphone app developed by the National Cancer Institute which uses smoking cessation recommendations contained in the US DHHS Clinical Practice Guidelines.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Description: All participants will receive an 8-week course of nicotine patches. They will start off with 4 weeks of 21mg/24 hours patches, then move to 2 weeks of 14mg/24 hours patches, and finally end with 2 weeks of 7mg/24 hours patches.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nicotine patch
Description: All participants will receive an 8-week course of nicotine patches. They will start off with 4 weeks of 21mg/24 hours patches, then move to 2 weeks of 14mg/24 hours patches, and finally end with 2 weeks of 7mg/24 hours patches.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smartphone coaching
Description: All participants will partake in over-the-phone smartphone coaching lead by the PI or a research assistant. This will be a time for participants to bring up any technical issues they are experiencing with the study smartphone or app.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Smartphone coaching
Description: All participants will partake in over-the-phone smartphone coaching lead by the PI or a research assistant. This will be a time for participants to bring up any technical issues they are experiencing with the study smartphone or app.
Study: NCT06230263

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Visual acuity test
Description: Assess near high-contrast visual acuity (40cm) using EyeChart PRO on an iPad.~Use the MNREAD app to measure:~Reading Acuity: Smallest font size read without errors. Critical Print Size: Smallest font size for peak reading speed. Maximum Reading Speed: Time to read comfortable font size, in words per minute. Reading Accessibility Index: Single metric summarizing visual access to print. Assess near visual function with the Near Activity Visual Questionnaire.~Evaluate distance visual acuity, both high and low contrast, using logMAR and the E-ETDRS (NIDEK SC-2000).

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Visual acuity test
Description: Assess near high-contrast visual acuity (40cm) using EyeChart PRO on an iPad.~Use the MNREAD app to measure:~Reading Acuity: Smallest font size read without errors. Critical Print Size: Smallest font size for peak reading speed. Maximum Reading Speed: Time to read comfortable font size, in words per minute. Reading Accessibility Index: Single metric summarizing visual access to print. Assess near visual function with the Near Activity Visual Questionnaire.~Evaluate distance visual acuity, both high and low contrast, using logMAR and the E-ETDRS (NIDEK SC-2000).
Study: NCT05402059

Intervention type: DRUG
Intervention: surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines
Description: Any kind of treatment or observation (no treatment) initiated or planned in accordance with current clinical practice

Intervention type: DRUG
Intervention: surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines
Description: Any kind of treatment or observation (no treatment) initiated or planned in accordance with current clinical practice

Intervention type: DRUG
Intervention: surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines
Description: Any kind of treatment or observation (no treatment) initiated or planned in accordance with current clinical practice

Intervention type: DRUG
Intervention: surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines
Description: Any kind of treatment or observation (no treatment) initiated or planned in accordance with current clinical practice

Intervention type: DRUG
Intervention: surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines
Description: Any kind of treatment or observation (no treatment) initiated or planned in accordance with current clinical practice
Study: NCT06201312

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: COP exercise
Description: crossover point intensity exercise

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: COP exercise
Description: crossover point intensity exercise
Study: NCT06212011

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Superimposed Neuromuscular Electrical Stimulation
Description: The superimposed technique involves the application of electrical stimulation during voluntary muscle contraction. In our study, in the superimposed neuromuscular electrical simulation group, neuromuscular electrical stimulation will be applied to the lumbar multifidus muscle while individuals perform the activity of standing up from sitting.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Neuromuscular Electrical Stimulation
Description: The conventional neuromuscular electrical simulation technique, electrical stimulation is applied without the individual performing voluntary contractions. In our study, conventional NMES will be applied to the lumbar multifidus muscle with the individual lying in the prone position and the individual will not elicit any voluntary contractions during the simulation.
Study: NCT05136599

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bordetella pertussis D420
Description: Intranasal inoculation of Bordetella pertussis D420 in each naris on Day 0 of the study.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bordetella pertussis D420
Description: Intranasal inoculation of Bordetella pertussis D420 in each naris on Day 0 of the study.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bordetella pertussis D420
Description: Intranasal inoculation of Bordetella pertussis D420 in each naris on Day 0 of the study.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bordetella pertussis D420
Description: Intranasal inoculation of Bordetella pertussis D420 in each naris on Day 0 of the study.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bordetella pertussis D420
Description: Intranasal inoculation of Bordetella pertussis D420 in each naris on Day 0 of the study.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bordetella pertussis D420
Description: Intranasal inoculation of Bordetella pertussis D420 in each naris on Day 0 of the study.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bordetella pertussis D420
Description: Intranasal inoculation of Bordetella pertussis D420 in each naris on Day 0 of the study.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bordetella pertussis D420
Description: Intranasal inoculation of Bordetella pertussis D420 in each naris on Day 0 of the study.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bordetella pertussis D420
Description: Intranasal inoculation of Bordetella pertussis D420 in each naris on Day 0 of the study.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bordetella pertussis D420
Description: Intranasal inoculation of Bordetella pertussis D420 in each naris on Day 0 of the study.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bordetella pertussis D420
Description: Intranasal inoculation of Bordetella pertussis D420 in each naris on Day 0 of the study.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bordetella pertussis D420
Description: Intranasal inoculation of Bordetella pertussis D420 in each naris on Day 0 of the study.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bordetella pertussis D420
Description: Intranasal inoculation of Bordetella pertussis D420 in each naris on Day 0 of the study.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bordetella pertussis D420
Description: Intranasal inoculation of Bordetella pertussis D420 in each naris on Day 0 of the study.
Study: NCT04890808

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Inosine
Description: Patients will be dosed with two 500 mg capsules of Inosine twice daily for 36 months

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: IP6
Description: Patients will be dosed with two 500 mg capsules of IP6 twice daily for 36 months
Study: NCT03303222

Intervention type: DIAGNOSTIC_TEST
Intervention: breath
Description: measurement of volatile compounds, such as TMAO in exhaled breath and blood

Intervention type: DIAGNOSTIC_TEST
Intervention: breath
Description: measurement of volatile compounds, such as TMAO in exhaled breath and blood
Study: NCT04807673

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Neoadjuvant period: pembrolizumab 200mg IV D1, Q3W, and preoperative therapy with three cycles.~Adjuvant period: pembrolizumab 200 mg IV D1, Q3W, up to one year, which should be performed within 3-6 weeks after surgery.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Neoadjuvant period: paclitaxel 135mg/m\^2 IV on Day 2 Q3W, and a total of three cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Neoadjuvant period: cisplatin 80 mg/m\^2 IV on Day 2 Q3W, and a total of three cycles.
Study: NCT06523712

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smile Smarts
Description: The interactive oral health care lessons provided to participants in Arm 1 would involve activities and discussions aimed at changing behaviors such as tooth brushing frequency, brushing techniques, and the use of interdental aids. The intervention aims to educate and motivate participants to adopt and maintain optimal oral hygiene habits through behavioral change strategies.
Study: NCT04807673

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: neoadjuvant chemoradiotherapy
Description: neoadjuvant chemoradiotherapy 41.4Gy(1.8Gy×23 fractions) with five cycles of TP(Paclitaxel 50mg/m\^2 on D1 and Cisplatin 25mg/m\^2 D1, repeated every week
Study: NCT04357054

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Darwish test
Description: Infertile women planned for combined laparoscopy and hysteroscopy as an integral part of infertility wok-up.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Darwish test
Description: Infertile women planned for combined laparoscopy and hysteroscopy as an integral part of infertility wok-up.
Study: NCT06204445

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Green coffee
Description: Each cup of coffee provides approximately 400 mg of hydroxycinnamic acids.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Roasted coffee
Description: Each cup of coffee provides approximately 150 mg of hydroxycinnamic acids.
Study: NCT05656235

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enfortumab vedotin
Description: Enfortumab vedotin 1.25mg/kg on Days 1 and 8 every 3 weeks for up to 35 weeks (each cycle = 21 days)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab 200mg on Day 1 every 3 weeks for up to 35 weeks (each cycle = 21 days)
Study: NCT06241547

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: electrical stimualtion via EmeTerm bracelet
Description: We planned to exert electrical stimulation via the bracelet.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: antimetic drugs（ dexamethasone，ondansetron）
Description: Antimetic drugs (dexamethasone ondansetron) are used to prevent postoperative nausea and vomiting.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: antimetic drugs（ dexamethasone，ondansetron）
Description: Antimetic drugs (dexamethasone ondansetron) are used to prevent postoperative nausea and vomiting.
Study: NCT04744272

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: myAsthma
Description: myAsthma is an online digital self-management application to support asthma patients by offering education, inhaler technique, pulmonary rehabilitation, symptoms and medication usage tracking remotely.
Study: NCT05272943

Intervention type: OTHER
Intervention: Oxgen saturation measurement with validated pulse oximetry
Description: Oxgen saturation will be measured with validated pulse oximetry

Intervention type: OTHER
Intervention: Oxgen saturation measurement with validated pulse oximetry
Description: Oxgen saturation will be measured with validated pulse oximetry

Intervention type: OTHER
Intervention: Oxgen saturation measurement with validated pulse oximetry
Description: Oxgen saturation will be measured with validated pulse oximetry

Intervention type: OTHER
Intervention: Oxgen saturation measurement with validated pulse oximetry
Description: Oxgen saturation will be measured with validated pulse oximetry

Intervention type: OTHER
Intervention: Oxgen saturation measurement with smart electronics
Description: Oxgen saturation will be measured with smart electronics

Intervention type: OTHER
Intervention: Oxgen saturation measurement with smart electronics
Description: Oxgen saturation will be measured with smart electronics

Intervention type: OTHER
Intervention: Oxgen saturation measurement with smart electronics
Description: Oxgen saturation will be measured with smart electronics

Intervention type: OTHER
Intervention: Oxgen saturation measurement with smart electronics
Description: Oxgen saturation will be measured with smart electronics
Study: NCT05589805

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy
Description: In addition to wrist splint, ESWT treatment (1.5 bar, 5Hz, 1000 beats) will be applied to the patients with Elmed Vibrolith Ortho brand ESWT device, which we routinely use in the treatment of carpal tunnel syndrome, for 3 weeks, once a week.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser therapy
Description: In addition to the wrist splint, the patients will be treated with the BTL-4110 Laser Topline model low-intensity laser device, which we routinely use in the treatment of carpal tunnel syndrome in our hospital, 5 days a week for 15 sessions of laser treatment.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: Patients will only be given a wrist splint to keep the wrist in neutral position.
Study: NCT04733027

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Dose escalation, first-in-human phase I clinical trial with an Expansion phase
Description: PEP-010 will be administered on days 1, 2 and 3 every week, as a 3-hour intravenous infusion. Treatment will be administered until disease progression, unacceptable toxicity, death or withdrawal of consent, whichever occurs first. Each cycle will be of 21 days duration.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Dose escalation, first-in-human phase I clinical trial with an Expansion phase
Description: PEP-010 will be administered on days 1, 2 and 3 every week, as a 3-hour intravenous infusion. Treatment will be administered until disease progression, unacceptable toxicity, death or withdrawal of consent, whichever occurs first. Each cycle will be of 21 days duration.
Study: NCT05436197

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PLAYshop Program
Description: The intervention includes: 1. Educational Training - the 60 min virtual/hybrid workshop will be delivered by a trained facilitator. Parents will be introduced to physical literacy via education, group discussion, and active participation in fundamental movement skills (FMS) based activities with their child. 2. Distribution of Education Resources- Parents will be provided with physical literacy and physical activity printed resources. 3. Material resources -parents will also be provided a bag of inexpensive active play equipment (e.g., ball, bean bag, balloons). 4. Provide Follow-up Support- After the workshop, participants will gain access to an app with an online toolkit including new active play ideas, tips, and equipment they can make at home for active play. Additionally, participants will receive four bi-weekly booster lessons that include key workshop messages, support and encouragement for parents, reflection and check-in questions, and new activities to try with their child.
Study: NCT06172751

Intervention type: OTHER
Intervention: no intervention
Description: not applicable, this is an observational retrospective data analysis study; no interventions in the study

Intervention type: OTHER
Intervention: no intervention
Description: not applicable, this is an observational retrospective data analysis study; no interventions in the study
Study: NCT05070442

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Norm-based messaging and peer comparison features
Description: Participants are shown a version of NUSMart which includes Nutri-Score labels that are enabled and displayed besides all the products in the store. Additionally, they are shown a video that gives them background information about Nutri-Score labels and describes the following features enabled in this intervention:~* Norm-based messaging will be displayed in the form of a happy or sad emoticon based on whether the participant's current basket average Nutri-Score (weighted by number of servings) is above or below other shoppers (Nutri-Score=3.98).~* Peer comparison will be implemented as a vertical ruler display of the participant's current basket average Nutri-Score (weighted by number of servings) as well as that of their peers.~Nutri-Score=3.98 was chosen as it is 10% better than the mean Nutri-Score of baskets purchased by participants in the Nutri-Score labelled intervention arm of a prior study.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Norm-based messaging and peer comparison features
Description: Participants are shown a version of NUSMart which includes Nutri-Score labels that are enabled and displayed besides all the products in the store. Additionally, they are shown a video that gives them background information about Nutri-Score labels and describes the following features enabled in this intervention:~* Norm-based messaging will be displayed in the form of a happy or sad emoticon based on whether the participant's current basket average Nutri-Score (weighted by number of servings) is above or below other shoppers (Nutri-Score=3.98).~* Peer comparison will be implemented as a vertical ruler display of the participant's current basket average Nutri-Score (weighted by number of servings) as well as that of their peers.~Nutri-Score=3.98 was chosen as it is 10% better than the mean Nutri-Score of baskets purchased by participants in the Nutri-Score labelled intervention arm of a prior study.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Financial Incentives leveraging on loss aversion
Description: Participants are informed that they have received an additional $5 towards their participant reimbursement. However, this amount will be forfeited if they check-out with a basket average Nutri-Score (weighted by the number of servings) that falls below the average Nutri-Score of other shoppers i.e. 3.98. An indicator on the screen that informs the participants of this potential forfeiting will be included.